The poorer ∆Ki672week in higher grade tumours or those with high Ki67, similarly to that in PgR- and HER2 + tumours indicates that those with biologically more aggressive disease but not higher stage disease (cf the data on tumour size and nodal status) have a poorer biologic response to oestrogen deprivation. The gene discussed is ERBB2; the disease is neoplasm.